About HEPCVEL TABLET
Sofosbuvir is used in the treatment of chronic hepatitis C virus (HCV) infection.
Velpatasvir works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.
Specification
|
Country of Origin
|
Made in India
|
|
Strength
|
400 + 100MG
|
|
Manufacturer
|
Cipla Ltd
|
|
Packaging Size
|
28 TAB
|
|
Prescription/Non prescription
|
Prescription
|
|
Treatment
|
sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infecti
|
|
Composition
|
SOFOSBUVIR AND VELPATASVIR
|
Comprehensive Hepatitis C TherapyHEPCVEL combines Sofosbuvir and Velpatasvir into a single tablet for effective management of chronic Hepatitis C infection. This combination works synergistically to target multiple steps in the viral replication process, improving the chance of clearing the infection.
Easy-to-Use Oral RegimenAs a film-coated, once-daily oral medication, HEPCVEL simplifies adherence for patients. The yellow, oval-shaped tablets are easy to swallow and designed to provide a predictable therapeutic effect when taken as directed.
Quality Assurance and Safe DeliveryDCGI approval certifies HEPCVELs safety and efficacy. With a 24-month shelf life, each bottle is securely packaged to maintain tablet integrity by protecting it from moisture and light. Storage below 30C ensures optimal potency for its prescribed duration.
FAQs of HEPCVEL TABLET:
Q: How should I take HEPCVEL Tablet for hepatitis C infection?
A: HEPCVEL Tablet should be taken orally, exactly as prescribed by your physician. Typically, it involves one tablet daily for 12 weeks, but the exact duration may vary according to your individual treatment plan. Try to take the tablet at the same time each day for best results.
Q: What conditions does HEPCVEL treat and who can use it?
A: HEPCVEL is indicated for adult patients diagnosed with chronic Hepatitis C infection. It is not recommended for individuals with a known hypersensitivity to its components or for those with severe renal impairment.
Q: When can I expect to see benefits from HEPCVEL treatment?
A: Most patients begin to see improvement in viral load during the course of a 12-week therapy. The exact response can vary depending on individual health factors and adherence to prescribed dosage.
Q: Where should I store HEPCVEL tablets, and what is their shelf life?
A: Store HEPCVEL tablets below 30C, away from moisture and direct light. Ensure the bottle is tightly closed. The product maintains its efficacy for up to 24 months from the date of manufacture.
Q: What are the main active ingredients in HEPCVEL and how do they work?
A: The active ingredients are Sofosbuvir 400mg and Velpatasvir 100mg. Together, they block proteins essential for hepatitis C virus replication, helping to clear the infection from your body.
Q: What are the advantages of using HEPCVEL over other regimens?
A: HEPCVEL offers the benefit of a fixed-dose, direct-acting antiviral single-tablet regimen, making it convenient and simplifying adherence for patients. Its broad antiviral action targets multiple genotypes of the hepatitis C virus.